400 million patients are affected by retinal diseases Their number is to double over the next 40 years Over 50% of cases remain undiagnosed 92 firms are developing new retinal therapies
Why do we advance retinal imaging?
Retinal diseases affect 400 million patients worldwide. Moreover 1 billion people suffer from other health conditions that impact the back of the eye, such as hypertension and diabetes. Unfortunately, early retinal symptoms are hard to detect and, as a result, massive numbers of cases remain undiagnosed.
While new therapies are reaching the market, doctors have the key role of choosing the best treatment option for each individual patient. Their task is difficult because it takes months to evaluate how a patient responds to a therapy. As a consequence, millions of people are being treated with drugs that are not optimal for them.
Imagine Eyes® addresses these major health issues with advanced biophotonics technology. We create new retinal imaging devices in order to help preserve sight, prevent handicap and save lives.